James Davidson

The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models

András Kotschy, Zoltán Szlávik, James B. Murray et al. · Nature · 2016 · 1K citations

Mcl1 Inhibitor S63845, Systems Biology, Oncology +11

Structure−Activity Relationships for Cytotoxic Ruthenium(II) Arene Complexes Containing N,N-, N,O-, and O,O-Chelating Ligands

Abraha Habtemariam, Michael Melchart, Rafael Fernández et al. · Journal of Medicinal Chemistry · 2006 · 449 citations

Kinetics of Aquation and Anation of Ruthenium(<scp>II</scp>) Arene Anticancer Complexes, Acidity and X‐ray Structures of Aqua Adducts

Fuyi Wang, Haimei Chen, Simon Parsons et al. · Chemistry - A European Journal · 2003 · 253 citations · Full text

S55746 is a novel orally active BCL-2 selective and potent inhibitor that impairs hematological tumor growth

Patrick Casara, James Davidson, Audrey Clapéron et al. · Oncotarget · 2018 · 109 citations · Full text

Discovery of S64315, a Potent and Selective Mcl-1 Inhibitor

Zoltán Szlávik, Márton Csékei, Attila Paczal et al. · Journal of Medicinal Chemistry · 2020 · 97 citations · Full text

Molecular Docking, Tumor Biology, Medicinal Chemistry +14